Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H8N2S4 |
Molecular Weight | 332.487 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
S(SC1=NC2=CC=CC=C2S1)C3=NC4=CC=CC=C4S3
InChI
InChIKey=AFZSMODLJJCVPP-UHFFFAOYSA-N
InChI=1S/C14H8N2S4/c1-3-7-11-9(5-1)15-13(17-11)19-20-14-16-10-6-2-4-8-12(10)18-14/h1-8H
Molecular Formula | C14H8N2S4 |
Molecular Weight | 332.487 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.accessdata.fda.gov/spl/data/b9c29578-0968-465e-a24b-19dabfb2d7dd/b9c29578-0968-465e-a24b-19dabfb2d7dd.xmlCurator's Comment: https://www.google.com/patents/US4755608; https://www.ncbi.nlm.nih.gov/pubmed/19158128; https://www.ncbi.nlm.nih.gov/pubmed/20197752; https://www.ncbi.nlm.nih.gov/pubmed/20197752; http://www.fda.gov/downloads/BiologicsBloodVaccines/Allergenics/UCM294327.pdf
Sources: http://www.accessdata.fda.gov/spl/data/b9c29578-0968-465e-a24b-19dabfb2d7dd/b9c29578-0968-465e-a24b-19dabfb2d7dd.xml
Curator's Comment: https://www.google.com/patents/US4755608; https://www.ncbi.nlm.nih.gov/pubmed/19158128; https://www.ncbi.nlm.nih.gov/pubmed/20197752; https://www.ncbi.nlm.nih.gov/pubmed/20197752; http://www.fda.gov/downloads/BiologicsBloodVaccines/Allergenics/UCM294327.pdf
2,2'-dithiobisbenzothiazole is a Standardized Chemical Allergen as labeled by US Food and Drug Administration. and can cause an allergic contact dermatitis.Its physiologic effect is by means of increased histamine release, and cell-mediated immunity. 2,2'-dithiobis(benzothiazole) is a useful compound in the rubber industry as a vulcanization accelerator. 2,2'-dithiobis(benzothiazole) was marketed to the rubber industry under the tradename Altax(TM) by the R. T. Vanderbilt Company, Inc. and was originally developed for safe processing of rubber compounds cured at above 142° C. 2,2'-dithiobis(benzothiazole) is widely used in compounds of all types for many major commercial applications. It may be carcinogenic for human. The mortality (1955-2005) and cancer morbidity experience (1971-2005) of a cohort of 363 male production workers exposed to MBT while employed at a chemical factory in north Wales showed a significant excess mortality for cancers of the large intestine.
Originator
Sources: https://www.google.com/patents/US4755608
Curator's Comment: was marketed to the rubber industry under the tradename Altax(TM) by the R. T. Vanderbilt Company, Inc.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | T.R.U.E. TEST Approved UseT.R.U.E. TEST(R) is an epicutaneous patch test indicated for use as an aid in the diagnosis of allergic
contact dermatitis (ACD) in persons 18 years of age and older whose history suggests sensitivity to one or more of the 35 substances included on the T.R.U.E. TEST panels. |
PubMed
Title | Date | PubMed |
---|---|---|
Inactivation of the human papillomavirus-16 E6 oncoprotein by organic disulfides. | 2000 Nov |
|
Determination of the sensitising activity of the rubber contact sensitisers TMTD, ZDMC, MBT and DEA in a modified local lymph node assay and the effect of sodium dodecyl sulfate pretreatment on local lymph node responses. | 2002 Jul 1 |
|
Diagnostic screening for contact allergy to mercaptobenzothiazole derivatives. | 2002 Jun |
|
Allergic contact dermatitis from rubber bands in 3 postal workers. | 2003 Dec |
|
Development and application of an LC-MS method to determine possible migration of mercaptobenzothiazole, benzothiazole and related vulcanization residues from rubber used in contact with food and drink. | 2003 Feb |
|
Occupational rubber glove allergy: results of the Information Network of Departments of Dermatology (IVDK), 1995-2001. | 2003 Jan |
|
[Allergy to mercaptobenzothiazole and mercapto mix]. | 2004 Aug-Sep |
|
Homolytic cleavage and aggregation processes in cyclopentadienylchromium chemistry. | 2004 Mar |
|
One-pot synthesis of high-quality zinc-blende CdS nanocrystals. | 2004 Nov 10 |
|
Contact dermatitis of the feet: a study of 53 cases. | 2004 Sep |
|
Mercaptobenzothiazole or the mercapto-mix: which should be in the standard series? | 2006 Jul |
|
Allergic contact dermatitis from mercapto compounds. | 2006 Jun |
|
Bikini dermatitis due to mercaptobenzothiazole. | 2006 Jun |
|
Both mercaptobenzothiazole and mercapto mix should be part of the standard series. | 2006 Nov |
|
Oxidation of 2-mercaptobenzothiazole in latex gloves and its possible haptenation pathway. | 2007 Aug |
|
Solid state differentiation of plasma thiols using a centrifugally activated mercaptobenzothiazole disulfide exchange indicator. | 2007 Feb 14 |
|
Chemical changes in rubber allergens during vulcanization. | 2007 Sep |
|
Mercaptobenzothiazole allergenicity-role of the thiol group. | 2008 |
|
The oxidative degradation of 2-mercaptobenzothiazole at the interface of beta-MnO2 and water. | 2008 Jun 15 |
|
Cancer risks in chemical production workers exposed to 2-mercaptobenzothiazole. | 2009 Apr |
|
Mercaptobenzothiazole-on-gold organic phase biosensor systems: 1. Enhanced organosphosphate pesticide determination. | 2009 Feb |
|
A case of airborne allergic contact dermatitis by rubber additives. | 2010 Feb |
Sample Use Guides
Apply the three adhesive panels of allergens and allergen mixes on healthy skin of the back. Remove panels and evaluate the skin 48 hours after application. Re-evaluate the skin 72 to 96 hours after application. Three adhesive panels consisting of 35 allergen and allergen mix patches and
a negative control. Panel 3.3 contains 12 allergens and allergen mixes including mercaptobenzothiazole (Position 32) (purity ≥98.5%) The gel vehicle is povidone. The product is formulated to contain 75 ug/cm2 of mercaptobenzothiazole, which corresponds to 61 ug of mercaptobenzothiazole per patch.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24478133
The cytotoxicity of 2-mercaptobenzothiazole [MBT] on bacteria was evaluated by the SOS/umu test using Salmonella typhimurium TA1535/pSK1002. MBT showed more than 50% cytotoxicity at its highest concentrations in a dose-dependent manner with LC50 of 19 mg/L.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:13 GMT 2023
by
admin
on
Fri Dec 15 15:16:13 GMT 2023
|
Record UNII |
6OK753033Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
||
|
EPA PESTICIDE CODE |
9202
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m4683
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | Merck Index | ||
|
N0000171131
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
100000134275
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
N0000184306
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
53239
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
120-78-5
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
C028000
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
SUB61034
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
1137
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
6OK753033Z
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
8447
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
6OK753033Z
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
2
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
N0000175629
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | Increased Histamine Release [PE] | ||
|
1306112
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID1020146
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY | |||
|
204-424-9
Created by
admin on Fri Dec 15 15:16:13 GMT 2023 , Edited by admin on Fri Dec 15 15:16:13 GMT 2023
|
PRIMARY |